Not recruiting yet
A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD
NCT05755607 · The First Affiliated Hospital of University of South China · Updated 6 March 2023
- What is being tested
- laparoscopic pancreaticoduodenectomy; Robot Pancreaticoduodenectomy
- For
- Pancreatic Cancer; Common Bile Duct Diseases; Periampullary Carcinoma
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 200 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started 1 June 2023, ends 1 July 2031. Registered 6 March 2023.
- Results
- None posted yet.
In the researchers' words
laparoscopic pancreaticoduodenectomy(LPD) and Robot Pancreaticoduodenectomy (RPD), as two minimally invasive methods of pancreaticoduodenectomy(PD), have obvious advantages over traditional open pancreaticoduodenectomy(OPD) in terms of reducing surgical trauma and hospitalization time, but there are few studies on their perioperative safety and prognostic effects.However, there are few studies on the perioperative safety and prognostic effects of both procedures. In this trial, the perioperative data and prognosis of both procedures were collected and analyzed through a prospective, multicenter approach to investigate the advantages and disadvantages of both procedures.